The Australian Financial Review, in its Street Talk column, reported that ResMed could be a takeover target for U.S. medical giants Medtronic Inc , St Jude Medical Inc , Boston Scientific Corp and German industrial gas group Linde AG
RMD Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held